Paragon Capital Management (Kansas)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-195
Closed -$210K 60
2025
Q4
$210K Buy
+195
New +$186K 0.11% 57
2024
Q4
Sell
-263
Closed -$233K 57
2024
Q3
$233K Buy
+263
New +$236K 0.12% 57
2020
Q2
Sell
-163
Closed -$23K 111
2020
Q1
$23K Buy
+163
New +$22.4K 0.02% 109

Other funds holding LLY

Paragon Capital Management (Kansas)'s LLY Position: Q1 2026 in Review

Paragon Capital Management (Kansas) sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 195 shares — an estimated $210K sold.

Paragon Capital Management (Kansas) first reported a position in LLY in Q1 2020 and held it in 3 quarters. The position peaked at $233K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Paragon Capital Management (Kansas) reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 195 Eli Lilly shares in Q1 2026, an estimated $210K.
  • Paragon Capital Management (Kansas) first reported a position in Eli Lilly in Q1 2020 and held it in 3 quarters.
  • Paragon Capital Management (Kansas)'s Eli Lilly position peaked at $233K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q1 2026, filed 15 May 2026.